This one comes in from Rob Fannon’s Medical Investor, another publication of Stansberry and Associates — we’ve seen a few of his teasers before, with actually some quite good results on their ideas for “SNiP Investments” and a few others. This time, as with so many Stansberry ads, there’s again an invented term to juice [...]
OK, so this one is cheating a little bit — I’ve already sleuthed out this recommendation, but this is a new way of selling it that I love. You see, they’re now teasing this company with Katie Couric’s story — not about how she became such a prominent newswoman, or America’s morning sweetheart, or any [...]
OK, so now that I’ve taken a moment to look at Investment #1 I probably could have just included it in my earlier post about the SNiP Technique teaser from Medical Investor. This is not such a tough one. But what’s done is done … so here ’tis: They teased two SNiP companies in the [...]
This is one of several companies that were teased by The Medical Investor (whose special report tease about a medical device I just wrote up earlier today). They’re basically arguing that this SNiP technique, which stands for single nucleotide polymorphism, is revolutionizing healthcare, and that you need to get involved with the companies that are [...]
Rob Fannon and Dr. George Huang are analysts for a newsletter called The Medical Investor, and their publisher, George Rayburn, has a deal for you … sign up for a subscription, and you’ll get their new report, “The Most Profitable New Medical Device Investment in the World Right Now.” Or of course, since you’re a [...]